Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/3/2021
Bayer's Nexavar Composition Patent Challenged and Invalidated in China
2/2/2021
More A Share-Listed Chinese MedPharm Cos Report 2020 Performance Guida...
2/2/2021
Harbour BioMed and ProBioGen Agree on a GlymaxX License to Fast-Track ...
2/2/2021
Astellas Granted Chinese Approval of XOSPATA (Gilteritinib)
2/2/2021
WuXi STA to Acquire BMS's Manufacturing Facility in Couvet, Switzerlan...
2/2/2021
Eli Lilly Reports 2020 Performance/2021 Outlook, Highlighting Volume G...
2/2/2021
Innovent and Lilly Announce Chinese Approval of TYVYT Combo for nsq...
2/2/2021
AZ's Chinese Partner Kangtai Bio Expects to Make 400M COVID-19 Vaccine...
2/2/2021
Bayer: Successfully Protected Legal Rights of "Kangwang" Trademark
2/1/2021
NHSA Issues Two Documents for Inter-provincial Direct Settlement of BM...
2/1/2021
CDE Issues the Technical Guidelines for Clinical Trials of Therapeutic...
2/1/2021
GSK Ends COVID-19 Vaccine Partnership with Clover
2/1/2021
Coherus and Junshi Enter Licensing Deal for Toripalimab in North Ameri...
2/1/2021
Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of...
2/1/2021
Legend Biotech Announces BCMA CAR-T Cilta-cel Accepted for Accelerated...
2/1/2021
Antengene Partners with WuXi Biologics / WuXi STA to Advance Antibody-...
2/1/2021
China Unveils Action Plan on Building High-Standard Market System with...
1/29/2021
Ascentage Granted Orphan Drug Designation to Bcl-2 Inhibitor APG-2575 ...
1/29/2021
CDE Issues the Guideline on Adaptive Designs for Clinical Trials
1/29/2021
Recent Executive Moves
1/29/2021
Financial-related Company News in Brief
1/29/2021
Review of In-licensing Deals of Chinese Pharma Companies in 2020
1/29/2021
Ten Chinese Biotech Startups May Gain Listings at the Shanghai STAR Bo...
1/29/2021
NMPA Holds National Drug Regulatory Conference, Highlighting Path Forw...
1/29/2021
Annual Review of the Chinese Pharmaceutical Sector in 2020 and Outlook...
1/28/2021
Revised Chinese Patent Examination Guidelines Took Effect from Januar...
1/28/2021
Chofn IP: Patent Protection of Multinational Joint Invention in China
1/28/2021
Chofn IP: Recordation of Patent License Agreement In China
1/28/2021
The 2020 China Report of the Lancet Countdown on Health and Climate Ch...
1/28/2021
Longyao Pharma Granted Chinese Approval for Clinical Trial of CD20-tar...
Page:
223
/
797
Total number of articles:
23885
:
[First]
[<<]
[221]
[222]
[223]
[224]
[225]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit